Aurobindo Pharma submits transcript of analyst call

28 Nov 2019 Evaluate

With reference to letter dated November 8, 2019 wherein the company has intimated the schedule of Investors/ Analysts call on November 13, 2019, Aurobindo Pharma has informed about submission of the Transcript of the analyst / investor call on the Unaudited Financial Results of the Company for the second quarter and half year ended September 30, 2019 and the same is being uploaded on the website of the Company and is available in the following web link: https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/. 

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1217.45 -6.20 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×